Actively Recruiting

Age: 18Years +
All Genders
NCT07443670

Voice Analysis to Detect Pulmonary Arterial Pressure Changes in Heart Failure

Led by Noah Labs · Updated on 2026-03-02

60

Participants Needed

3

Research Sites

89 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

VAPP-HF is a prospective, multi-center, observational study assessing whether daily voice recordings analyzed by a machine learning algorithm can detect changes in pulmonary arterial (PA) pressure in heart failure patients with implanted PA pressure sensors (e.g., CardioMEMS, Cordella). Patients across three sites in Germany and the United States provide daily voice recordings via a mobile app for 12 weeks while continuing standard PA pressure monitoring and heart failure care. Voice data is analyzed retrospectively after study completion; no clinical decisions are based on voice analysis during the study. The primary endpoint is the sensitivity and specificity of the AI-based voice analysis in detecting PA pressure changes at defined thresholds.

CONDITIONS

Official Title

Voice Analysis to Detect Pulmonary Arterial Pressure Changes in Heart Failure

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Successful implantation of a PA pressure sensor and monitored by a participating study center
  • Willingness to record a short predefined text daily for 3 months using a smartphone or tablet
  • Ability to comfortably read aloud the study passage in English or German
  • Written informed consent obtained
Not Eligible

You will not qualify if you...

  • Pregnant, breastfeeding, or unwilling to practice birth control during participation
  • Condition that in the opinion of the investigator would compromise patient safety or data quality
  • Pathological voice changes due to surgery or injury
  • Planned invasive cardiac procedures during the study period
  • COPD requiring home oxygen therapy
  • Chronic kidney disease requiring dialysis
  • Cognitive dysfunction limiting ability to perform daily voice recording
  • Inability to read English or German
  • Physical inability to use the recording device

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

University of California, San Francisco (UCSF)

San Francisco, California, United States, 94143

Actively Recruiting

2

BG Klinikum Unfallkrankenhaus Berlin, Dept. of Cardiology

Berlin, State of Berlin, Germany, 12683

Completed

3

University Hospital Frankfurt, Dept. of Cardiology and Angiology

Frankfurt, Germany, 60590

Completed

Loading map...

Research Team

L

Leonhard Riehle, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here